VERTEX PHARMACEUTICALS INC / MA Insider Trading for April 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for April 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 18 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 90.29 | 2,125 | 191,866 | 10,625 | |
| Apr 18 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 122.45 | 4,250 | 520,413 | 12,750 | |
| Apr 18 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 184.42 | 400 | 73,768 | 35,003 | 35.4 K to 35 K (-1.13 %) |
| Apr 18 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 183.15 | 100 | 18,315 | 35,403 | 35.5 K to 35.4 K (-0.28 %) |
| Apr 18 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 182.24 | 600 | 109,344 | 35,503 | 36.1 K to 35.5 K (-1.66 %) |
| Apr 18 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 181.49 | 600 | 108,894 | 36,103 | 36.7 K to 36.1 K (-1.63 %) |
| Apr 18 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 179.84 | 425 | 76,432 | 36,703 | 37.1 K to 36.7 K (-1.14 %) |
| Apr 18 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 90.29 | 2,125 | 191,866 | 37,128 | 35 K to 37.1 K (+6.07 %) |
| Apr 18 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 184.44 | 660 | 121,730 | 35,003 | 35.7 K to 35 K (-1.85 %) |
| Apr 18 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 183.26 | 300 | 54,978 | 35,663 | 36 K to 35.7 K (-0.83 %) |
| Apr 18 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 182.19 | 1,605 | 292,415 | 35,963 | 37.6 K to 36 K (-4.27 %) |
| Apr 18 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 181.31 | 815 | 147,768 | 37,568 | 38.4 K to 37.6 K (-2.12 %) |
| Apr 18 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 179.91 | 870 | 156,522 | 38,383 | 39.3 K to 38.4 K (-2.22 %) |
| Apr 18 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 122.45 | 4,250 | 520,413 | 39,253 | 35 K to 39.3 K (+12.14 %) |
| Apr 17 2019 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | A | 0.00 | 247 | 0 | 9,577 | |
| Apr 17 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 183.61 | 320 | 58,755 | 33,240 | 33.6 K to 33.2 K (-0.95 %) |
| Apr 17 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 182.29 | 2,712 | 494,370 | 33,560 | 36.3 K to 33.6 K (-7.48 %) |
| Apr 17 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 180.95 | 2,592 | 469,022 | 36,272 | 38.9 K to 36.3 K (-6.67 %) |
| Apr 12 2019 | VRTX | VERTEX PHARMACEUTI ... | WAGNER CHARLES F JR | EVP and CFO | Option Exercise | A | 189.38 | 9,532 | 1,805,170 | 9,532 | |
| Apr 12 2019 | VRTX | VERTEX PHARMACEUTI ... | WAGNER CHARLES F JR | EVP and CFO | Grant | A | 0.00 | 3,697 | 0 | 3,697 | 0 to 3.7 K |